What is CK-MB Mass (Quantitative Test)? CK-MB (Creatine Kinase MB) is an isoenzyme of creatine kinase primarily found in the heart muscle (myocardium). The CK-MB Mass test measures the concentration of CK-MB protein in the blood (rather than its enzymatic activity), expressed in mass units (e.g., µg/L, ng/mL). Elevated CK-MB mass levels are a specific indicator of myocardial damage, such as in acute myocardial infarction (heart attack), and are more sensitive and specific than activity-based tests.
Definition: The CK-MB Mass Unit Converter converts the concentration of CK-MB protein between various units, enabling standardization of laboratory results for clinical use.
Purpose: It assists clinicians and researchers in interpreting CK-MB mass levels across different measurement units (e.g., µg/L to ng/mL), ensuring accurate diagnosis and management of cardiac conditions.
The converter uses µg/L as the base unit and converts between the following units:
Steps:
Converting CK-MB mass concentrations between units is critical for:
Elevated Levels: Elevated CK-MB mass levels are highly specific for myocardial damage, commonly seen in acute myocardial infarction, myocarditis, or cardiac trauma. Levels typically rise within 3–6 hours of injury, peak at 12–24 hours, and return to normal within 48–72 hours.
Normal Ranges:
Interferences:
Q: Why are there different units for CK-MB mass?
A: Different units reflect varying standards; µg/L and ng/mL are commonly used in clinical practice, while others like ng/dL are used in specific contexts.
Q: What is a normal CK-MB mass level?
A: Normal CK-MB mass is typically < 5 µg/L (< 5 ng/mL). Elevated levels may indicate heart damage—consult a healthcare provider for interpretation.
Q: Can this converter be used for other biomarkers?
A: No, this converter is specific to CK-MB mass; other biomarkers have different conversion factors—consult a healthcare provider for accuracy.